GENE ONLINE|News &
Opinion
Blog

Heart Failure
AstraZeneca’s Forxiga Gets EU Nod To Treat Symptomatic Chronic Heart Failure
2023-02-08
Uncovering Racial Disparities in End-stage Heart Failure Therapies
2022-11-02
EC Approves New Indication for Teysuno to Address Hand-Foot Syndrome and Cardiotoxicity
2022-02-07
Eli Lilly and Boehringer Ingelheim’s Jardiance Shows Encouraging Phase 3 HFpEF Data
2021-07-07
Japanese Biotech Raises $37 Million in Series C to Develop Stem Cell Therapy for Heart Failure
2021-06-13
Forxiga Gains Approval in China for Multiple Cardio-Related Diseases
2021-02-07
Merck and Bayer Enter the Congested Market of Heart Failure with Verquvo
2021-01-21
A Review of Neurological Symptoms in COVID-19 Patients
2020-05-18
ACE2: A Valuable Biomarker for COVID19 Susceptibility in Heart Patients
2020-05-16
R&D
Spotlight: The Many Facets of AstraZeneca’s Farxiga
2020-05-15
MyoKardia Announces Positive Topline Results for Targeted Cardiomyopathy Drug
2020-05-13
LATEST
Innovative Cellular Mapping of BRCA-Related Breast Cancer Findings Reveals Novel Therapeutic Targets
2024-03-29
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top